ArticleBritish journal of pharmacology2008

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

C Dianzani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.